These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17573400)

  • 41. Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery.
    Ho KM; Morgan DJ
    Am J Kidney Dis; 2009 Jan; 53(1):33-40. PubMed ID: 18649982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac surgery in end-stage renal failure patients.
    Sirch J; Weyand M; Pfeiffer S
    Am J Kidney Dis; 2003 Nov; 42(5):1105-6; author reply 1106. PubMed ID: 14582061
    [No Abstract]   [Full Text] [Related]  

  • 43. Volatile anesthetics in cardiac surgery: renoprotective, cardioprotective, neither, or both?
    Andersen ND
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3137-8. PubMed ID: 25433889
    [No Abstract]   [Full Text] [Related]  

  • 44. Remote ischaemic pre-conditioning for the prevention of acute kidney injury.
    Ho PW; Pang WF; Szeto CC
    Nephrology (Carlton); 2016 Apr; 21(4):274-85. PubMed ID: 26370466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
    Rizzato G
    Radiol Med; 2001 Apr; 101(4):287-9. PubMed ID: 11398061
    [No Abstract]   [Full Text] [Related]  

  • 46. How to protect from contrast media-induced nephropathy?
    Scheller B
    Clin Res Cardiol; 2007 Mar; 96(3):125-9. PubMed ID: 17294353
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention of acute kidney injury.
    Brincat S; Hilton R
    Br J Hosp Med (Lond); 2008 Aug; 69(8):450-4. PubMed ID: 18783092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Off-pump coronary artery bypass grafting may prevent acute renal failure in patients with non-dialysis dependent chronic renal dysfunction: an aggregate meta-analysis.
    Lim JY; Deo SV; Altarabsheh SE; Cho YH; Shin E; Markowitz AH
    Int J Cardiol; 2015 Mar; 182():181-3. PubMed ID: 25577759
    [No Abstract]   [Full Text] [Related]  

  • 49. Beyond the
    McDonald JS
    AJR Am J Roentgenol; 2023 May; 220(5):761. PubMed ID: 36069487
    [No Abstract]   [Full Text] [Related]  

  • 50. Bridging Translation by Improving Preclinical Study Design in AKI.
    de Caestecker M; Humphreys BD; Liu KD; Fissell WH; Cerda J; Nolin TD; Askenazi D; Mour G; Harrell FE; Pullen N; Okusa MD; Faubel S;
    J Am Soc Nephrol; 2015 Dec; 26(12):2905-16. PubMed ID: 26538634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of an acute dose of L-arginine during coronary angiography in patients with chronic renal failure: a randomized, parallel, double-blind clinical trial.
    Miller HI; Dascalu A; Rassin TA; Wollman Y; Chernichowsky T; Iaina A
    Am J Nephrol; 2003; 23(2):91-5. PubMed ID: 12481147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pretreatment with pentoxifylline and N-acetylcysteine in liver ischemia reperfusion-induced renal injury.
    Seifi B; Kadkhodaee M; Delavari F; Mikaeili S; Shams S; Ostad SN
    Ren Fail; 2012; 34(5):610-5. PubMed ID: 22364443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of N-acetylcysteine and ozone therapy on oxidative stress and inflammation in acetaminophen-induced nephrotoxicity model.
    Ucar F; Taslipinar MY; Alp BF; Aydin I; Aydin FN; Agilli M; Toygar M; Ozkan E; Macit E; Oztosun M; Cayci T; Ozcan A
    Ren Fail; 2013; 35(5):640-7. PubMed ID: 23560513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
    Shalby AB; Assaf N; Ahmed HH
    Toxicol Mech Methods; 2011 Sep; 21(7):538-46. PubMed ID: 21470069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renoprotective effect of high periprocedural doses of oral N-acetylcysteine in patients scheduled to undergo a same-day angiography.
    Balderramo DC; Verdu MB; Ramacciotti CF; Cremona LS; Lemos PA; Orías M; Eduardo M
    Rev Fac Cien Med Univ Nac Cordoba; 2004; 61(2):13-9. PubMed ID: 16211988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass.
    Song JW; Shim JK; Soh S; Jang J; Kwak YL
    Nephrology (Carlton); 2015 Feb; 20(2):96-102. PubMed ID: 25384603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
    Hsu SP; Chiang CK; Yang SY; Chien CT
    Nephron Clin Pract; 2010; 116(3):c207-16. PubMed ID: 20606481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions.
    Buyukhatipoglu H; Sezen Y; Yildiz A; Bas M; Kirhan I; Ulas T; Turan MN; Taskin A; Aksoy N
    Pol Arch Med Wewn; 2010 Oct; 120(10):383-9. PubMed ID: 20980943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What are the factors affecting the progression of kidney failure mortality and morbidity after cardiac surgery in patients with chronic kidney disease?
    Arif H; Khatri M; Kumar S
    J Card Surg; 2022 Aug; 37(8):2495-2496. PubMed ID: 35488785
    [No Abstract]   [Full Text] [Related]  

  • 60. Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.
    Perna AF; Sepe I; Lanza D; Pollastro RM; De Santo NG; Ingrosso D
    J Ren Nutr; 2012 Jan; 22(1):191-4. PubMed ID: 22200441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.